Additionally, factors such as oxidative stress, chronic inflammation, certain anti-diabetic medications, erythropoietin hypo-responsiveness, diabetic neuropathy, elevated levels of advanced glycation end products, and impaired erythropoietin response could contribute to anemia in individuals with T2DM [29, 30]. The gene discussed is EPO; the disease is type 2 diabetes mellitus.